Követés
Betty Lau
Betty Lau
Research Associate, University of Glasgow
E-mail megerősítve itt: glasgow.ac.uk
Cím
Hivatkozott rá
Hivatkozott rá
Év
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
MR Wills, E Poole, B Lau, B Krishna, JH Sinclair
Cellular & molecular immunology 12 (2), 128-138, 2015
1492015
The expression of human cytomegalovirus microRNA MiR-UL148D during latent infection in primary myeloid cells inhibits activin A-triggered secretion of IL-6
B Lau, E Poole, B Krishna, I Montanuy, MR Wills, E Murphy, J Sinclair
Scientific reports 6 (1), 1-15, 2016
842016
Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
BA Krishna, K Spiess, EL Poole, B Lau, S Voigt, TN Kledal, ...
Nature communications 8 (1), 1-9, 2017
692017
Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses
ECY Wang, M Pjechova, K Nightingale, VM Vlahava, M Patel, E Ruckova, ...
Proceedings of the National Academy of Sciences 115 (19), 4998-5003, 2018
612018
Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells
BA Krishna, B Lau, SE Jackson, MR Wills, JH Sinclair, E Poole
Scientific reports 6, 24674, 2016
582016
Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcγRIIB (CD32B)
EL Williams, AL Tutt, RR French, HT Chan, B Lau, CA Penfold, ...
European journal of immunology 42 (8), 2109-2120, 2012
552012
Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early-gene expression during latency to prevent T-cell recognition of latently infected cells
B Lau, E Poole, E Van Damme, L Bunkens, M Sowash, H King, E Murphy, ...
The Journal of general virology 97 (9), 2387, 2016
532016
Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+ R+ liver transplant patients
E Van Damme, S Sauviller, B Lau, B Kesteleyn, P Griffiths, A Burroughs, ...
The Journal of general virology 96 (Pt 1), 131, 2015
422015
Human cytomegalovirus long noncoding RNA4. 9 regulates viral DNA replication
J Tai-Schmiedel, S Karniely, B Lau, A Ezra, E Eliyahu, A Nachshon, ...
PLoS Pathogens 16 (4), e1008390, 2020
312020
Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins
R Beelontally, GS Wilkie, B Lau, CJ Goodmaker, CMK Ho, CM Swanson, ...
Antiviral research 138, 61-67, 2017
142017
Human cytomegalovirus long non-coding RNA1. 2 suppresses extracellular release of the pro-inflammatory cytokine IL-6 by blocking NF-κB activation
B Lau, K Kerr, Q Gu, K Nightingale, R Antrobus, NM Suárez, RJ Stanton, ...
Frontiers in cellular and infection microbiology 10, 361, 2020
122020
Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo
NM Suárez, B Lau, GM Kemble, R Lee, ES Mocarski, GWG Wilkinson, ...
Virus genes 53 (4), 650-655, 2017
122017
Corrigendum: the expression of human cytomegalovirus MicroRNA MiR-UL148D during latent infection in primary myeloid cells inhibits activin A-triggered secretion of IL-6
B Lau, E Poole, B Krishna, I Montanuy, MR Wills, E Murphy, J Sinclair
Scientific reports 6, 2016
32016
Insights into the roles of viral miRNAs, IE72 downregulation and myeloid differentiation during human cytomegalovirus latency and reactivation
BCM Lau
University of Cambridge, 2015
2015
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–14